Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 4/2018

01-04-2018 | Original Article

Impact of improved attenuation correction featuring a bone atlas and truncation correction on PET quantification in whole-body PET/MR

Authors: Mark Oehmigen, Maike E. Lindemann, Marcel Gratz, Julian Kirchner, Verena Ruhlmann, Lale Umutlu, Jan Ole Blumhagen, Matthias Fenchel, Harald H. Quick

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 4/2018

Login to get access

Abstract

Purpose

Recent studies have shown an excellent correlation between PET/MR and PET/CT hybrid imaging in detecting lesions. However, a systematic underestimation of PET quantification in PET/MR has been observed. This is attributable to two methodological challenges of MR-based attenuation correction (AC): (1) lack of bone information, and (2) truncation of the MR-based AC maps (μmaps) along the patient arms. The aim of this study was to evaluate the impact of improved AC featuring a bone atlas and truncation correction on PET quantification in whole-body PET/MR.

Methods

The MR-based Dixon method provides four-compartment μmaps (background air, lungs, fat, soft tissue) which served as a reference for PET/MR AC in this study. A model-based bone atlas provided bone tissue as a fifth compartment, while the HUGE method provided truncation correction. The study population comprised 51 patients with oncological diseases, all of whom underwent a whole-body PET/MR examination. Each whole-body PET dataset was reconstructed four times using standard four-compartment μmaps, five-compartment μmaps, four-compartment μmaps + HUGE, and five-compartment μmaps + HUGE. The SUVmax for each lesion was measured to assess the impact of each μmap on PET quantification.

Results

All four μmaps in each patient provided robust results for reconstruction of the AC PET data. Overall, SUVmax was quantified in 99 tumours and lesions. Compared to the reference four-compartment μmap, the mean SUVmax of all 99 lesions increased by 1.4 ± 2.5% when bone was added, by 2.1 ± 3.5% when HUGE was added, and by 4.4 ± 5.7% when bone + HUGE was added. Larger quantification bias of up to 35% was found for single lesions when bone and truncation correction were added to the μmaps, depending on their individual location in the body.

Conclusion

The novel AC method, featuring a bone model and truncation correction, improved PET quantification in whole-body PET/MR imaging. Short reconstruction times, straightforward reconstruction workflow, and robust AC quality justify further routine clinical application of this method.
Literature
1.
Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000;41(8):1369–79.PubMed
2.
Delso G, Fürst S, Jakoby B, et al. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med. 2011;52:1914–22.CrossRefPubMed
3.
Carney JP, Townsend DW, Rappoport V, Bendriem B. Method for transforming CT images for attenuation correction in PET/CT imaging. Med Phys. 2006;33:976–83.CrossRefPubMed
4.
Kinahan PE, Townsend DW, Beyer T, et al. Attenuation correction for a combined 3D PET/CT scanner. Med Phys. 1998;25(10):2046–53.CrossRefPubMed
5.
Keereman V, Mollet P, Berker Y, et al. Challenges and current methods for attenuation correction in PET/MR. MAGMA. 2013;26(1):81–98.CrossRefPubMed
6.
Bezrukov I, Schmidt H, Mantlik F, et al. MR-based attenuation correction methods for improved PET quantification in lesions within bone and susceptibility artifact regions. J Nucl Med. 2013;54(10):1768–74.CrossRefPubMed
7.
Martinez-Möller A, Souvatzoglou M, Delso G, et al. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med. 2009;50:520–6.CrossRefPubMed
8.
Schulz V, Torres-Espallardo I, et al. Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data. Eur J Nucl Med Mol Imaging. 2011;38(1):138–52.CrossRefPubMed
9.
Drzezga A, Souvatzoglou M, Eiber M, et al. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses. J Nucl Med. 2012;53(6):845–55.CrossRefPubMed
10.
Wiesmüller M, Quick HH, Navalpakkam B, et al. Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT. Eur J Nucl Med Mol Imaging. 2013;40(1):12–21.CrossRefPubMed
11.
Quick HH, von Gall C, Zeilinger M, et al. Integrated whole-body PET/MR hybrid imaging: clinical experience. Invest Radiol. 2013;48:280–9.CrossRefPubMed
12.
Beyer T, Lassen ML, Boellaard R, et al. Investigating the state-of-the-art in whole-body MR-based attenuation correction: an intra-individual, inter-system, inventory study on three clinical PET/MR systems. MAGMA. 2016;29:75–87.CrossRefPubMed
13.
Boellaard R, Quick HH. Current image acquisition options in PET/MR. Semin Nucl Med. 2015;45(3):192–200.CrossRefPubMed
14.
Nuyts J, Bal G, Kehren F, et al. Completion of a truncated attenuation image from the attenuated PET emission data. IEEE Trans Med Imaging. 2013;32:237–46.CrossRefPubMed
15.
Samarin A, Burger C, Wollenweber SD, et al. PET/MR imaging of bone lesions – implications for PET quantification from imperfect attenuation correction. Eur J Nucl Med Mol Imaging. 2012;39(7):1154–60.CrossRefPubMed
16.
Hofmann M, Bezrukov I, Mantlik F, et al. MRI-based attenuation correction for whole-body PET/MRI: quantitative evaluation of segmentation- and atlas-based methods. J Nucl Med. 2011;52(9):1392–9.CrossRefPubMed
17.
Paulus DH, Quick HH, Geppert C, et al. Whole-body PET/MR imaging: quantitative evaluation of a novel model-based MR attenuation correction method including bone. J Nucl Med. 2015;56:1061–6.CrossRefPubMedPubMedCentral
18.
Koesters T, Friedman KP, Fenchel M, et al. Dixon sequence with superimposed model-based bone compartment provides highly accurate PET/MR attenuation correction of the brain. J Nucl Med. 2016;57(6):918–24.CrossRefPubMedPubMedCentral
19.
Delso G, Martinez-Möller A, Bundschuh RA, et al. The effect of limited MR field of view in MR/PET attenuation correction. Med Phys. 2010;37(6):2804–12.CrossRefPubMed
20.
Bal G, Kehren F, Michel C, et al. Clinical evaluation of MLAA for MR-PET. J Nucl Med. 2011;52 Suppl 1:263.
21.
Blumhagen JO, Ladebeck R, Fenchel M, et al. MR-based field-of-view extension in MR/PET: B0 homogenization using gradient enhancement (HUGE). Magn Reson Med. 2013;70(4):1047–57.CrossRefPubMed
22.
Blumhagen JO, Braun H, Ladebeck R, et al. Field of view extension and truncation correction for MR-based human attenuation correction in simultaneous MR/PET imaging. Med Phys. 2014;41(2):022303.CrossRefPubMed
23.
24.
Delso G, Martinez-Möller A, Bundschuh RA, et al. Evaluation of the attenuation properties of MR equipment for its use in a whole-body PET/MR scanner. Phys Med Biol. 2010;55(15):4361–74.CrossRefPubMed
25.
Paulus DH, Tellmann L, Quick HH. Towards improved hardware component attenuation correction in PET/MR hybrid imaging. Phys Med Biol. 2013;58:8021–40.CrossRefPubMed
26.
Oehmigen M, Lindemann ME, Lanz T, et al. Integrated PET/MR breast cancer imaging: attenuation correction and implementation of a 16-channel RF coil. Med Phys. 2016;43(8):4808.CrossRefPubMed
27.
Aklan B, Paulus DH, Wenkel E, et al. Toward simultaneous PET/MR breast imaging: systematic evaluation and integration of a radiofrequency breast coil. Med Phys. 2013;40:024301.CrossRefPubMed
28.
Paulus DH, Braun H, Aklan B, et al. Simultaneous PET/MR imaging: MR-based attenuation correction of local radiofrequency surface coils. Med Phys. 2012;39(7):4306–15.CrossRefPubMed
29.
Kartmann R, Paulus DH, Braun H, et al. Integrated PET/MR imaging: automatic attenuation correction of flexible RF coils. Med Phys. 2013;40(8):082301.CrossRefPubMed
30.
Breuer FA, Blaimer M, Heidemann RM, et al. Controlled aliasing in parallel imaging results in higher acceleration (CAIPIRINHA) for multi-slice imaging. Magn Reson Med. 2005;53(3):684–91.CrossRefPubMed
31.
Rausch I, Rischka L, Ladefoged CN, et al. PET/MRI for oncologic brain imaging: a comparison of standard MR-based attenuation corrections with a model-based approach for the Siemens mMR PET/MR system. J Nucl Med. 2017;58(9):1519–25.CrossRefPubMed
32.
Lindemann ME, Oehmigen M, Blumhagen JO, et al. MR-based truncation and attenuation correction in integrated PET/MR hybrid imaging using HUGE with continuous table motion. Med Phys. 2017;44(9):4559–72.CrossRefPubMed
Metadata
Title
Impact of improved attenuation correction featuring a bone atlas and truncation correction on PET quantification in whole-body PET/MR
Authors
Mark Oehmigen
Maike E. Lindemann
Marcel Gratz
Julian Kirchner
Verena Ruhlmann
Lale Umutlu
Jan Ole Blumhagen
Matthias Fenchel
Harald H. Quick
Publication date
01-04-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 4/2018
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-017-3864-4

Other articles of this Issue 4/2018

European Journal of Nuclear Medicine and Molecular Imaging 4/2018 Go to the issue

Original Article

Tumour functional sphericity from PET images: prognostic value in NSCLC and impact of delineation method

Image of the Month

Anaplastic thyroid carcinoma on 68 Ga-PSMA PET/CT: opening new frontiers

Original Article

Up-front PET/CT changes treatment intent in patients with head and neck squamous cell carcinoma

Correction

Correction to: Dosimetry in clinical radionuclide therapy: the devil is in the detail

Original Article

Preclinical evaluation of an 18F-trifluoroborate methionine derivative for glioma imaging

Original Article

11C–MET PET/MRI for detection of recurrent glioma